Q2 Earnings Estimate for CAPR Issued By HC Wainwright
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – HC Wainwright issued their Q2 2025 earnings estimates for Capricor Therapeutics in a report issued on Thursday, March 20th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology company will post earnings of ($0.36) per share for the quarter. HC Wainwright currently has a “Buy” rating and […]
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – HC Wainwright issued their Q2 2025 earnings estimates for Capricor Therapeutics in a report issued on Thursday, March 20th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology company will post earnings of ($0.36) per share for the quarter. HC Wainwright currently has a “Buy” rating and […]
